Free Trial
Tada emoji MarketBeat All Access — Now Just $5.00 for 5 Weeks

Silence Therapeutics (SLN) SEC Filings & 10K Form

Silence Therapeutics logo
$5.35 -0.11 (-2.01%)
Closing price 08/22/2025 04:00 PM Eastern
Extended Trading
$5.35 0.00 (0.00%)
As of 08/22/2025 04:10 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.
Compare

Recent Silence Therapeutics SEC Filings

Export to Excel
DateFilerForm TypeView
08/14/2025
5:30 AM		Silence Therapeutics plc (Filer)
Silence Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/07/2025
7:04 AM		Silence Therapeutics plc (Filer)
Silence Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/07/2025
6:35 AM		Silence Therapeutics plc (Filer)
Silence Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/04/2025
7:03 AM		Griffiths Richard Ian (Reporting)
Silence Therapeutics plc (Issuer)
Silence Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/31/2025
7:43 AM		Griffiths Richard Ian (Reporting)
Silence Therapeutics plc (Issuer)
Silence Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/23/2025
1:22 PM		Griffiths Richard Ian (Reporting)
Silence Therapeutics plc (Issuer)
Silence Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/16/2025
1:58 PM		Griffiths Richard Ian (Reporting)
Silence Therapeutics plc (Issuer)
Silence Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/10/2025
7:36 AM		Griffiths Richard Ian (Reporting)
Silence Therapeutics plc (Issuer)
Silence Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/30/2025
11:31 AM		Griffiths Richard Ian (Reporting)
Silence Therapeutics plc (Issuer)
Silence Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/27/2025
6:00 AM		Silence Therapeutics plc (Filer)
Silence Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/25/2025
9:24 AM		Griffiths Richard Ian (Filed by)
Silence Therapeutics plc (Subject)
Silence Therapeutics (Subject)
Form SCHEDULE 13D/A
06/25/2025
7:59 AM		Griffiths Richard Ian (Reporting)
Silence Therapeutics plc (Issuer)
Silence Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/20/2025
5:46 AM		Griffiths Richard Ian (Reporting)
Silence Therapeutics plc (Issuer)
Silence Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/13/2025
7:06 AM		Griffiths Richard Ian (Reporting)
Silence Therapeutics plc (Issuer)
Silence Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/29/2025
10:21 AM		Griffiths Richard Ian (Reporting)
Silence Therapeutics plc (Issuer)
Silence Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/27/2025
7:35 AM		Griffiths Richard Ian (Reporting)
Silence Therapeutics plc (Issuer)
Silence Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/21/2025
5:49 AM		Griffiths Richard Ian (Reporting)
Silence Therapeutics plc (Issuer)
Silence Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/20/2025
3:12 PM		MCINERNEY TIMOTHY (Reporting)
Silence Therapeutics plc (Issuer)
Silence Therapeutics (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
05/20/2025
3:14 PM		MCINERNEY TIMOTHY (Reporting)
Silence Therapeutics plc (Issuer)
Silence Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/16/2025
5:05 AM		Silence Therapeutics plc (Filer)
Silence Therapeutics (Filer)
Form DEF 14A
05/16/2025
5:07 AM		Silence Therapeutics plc (Filer)
Silence Therapeutics (Filer)
Form ARS
05/15/2025
8:02 PM		Redmile Group, LLC (Filed by)
Silence Therapeutics plc (Subject)
Silence Therapeutics (Subject)
Form SCHEDULE 13G/A
05/08/2025
9:18 AM		Griffiths Richard Ian (Filed by)
Silence Therapeutics plc (Subject)
Silence Therapeutics (Subject)
Form SCHEDULE 13D/A
05/08/2025
7:10 AM		Silence Therapeutics plc (Filer)
Silence Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/08/2025
7:35 AM		Silence Therapeutics plc (Filer)
Silence Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/08/2025
6:08 AM		Griffiths Richard Ian (Reporting)
Silence Therapeutics plc (Issuer)
Silence Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/06/2025
7:03 AM		Silence Therapeutics plc (Filer)
Silence Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/06/2025
7:06 AM		Silence Therapeutics plc (Filer)
Silence Therapeutics (Filer)
Form PRE 14A
05/02/2025
9:28 AM		Griffiths Richard Ian (Reporting)
Silence Therapeutics plc (Issuer)
Silence Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/30/2025
6:13 AM		Griffiths Richard Ian (Reporting)
Silence Therapeutics plc (Issuer)
Silence Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/28/2025
5:50 AM		Griffiths Richard Ian (Reporting)
Silence Therapeutics plc (Issuer)
Silence Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/24/2025
8:28 AM		Griffiths Richard Ian (Filed by)
Silence Therapeutics plc (Subject)
Silence Therapeutics (Subject)
Form SCHEDULE 13D/A
04/24/2025
6:16 AM		Griffiths Richard Ian (Reporting)
Silence Therapeutics plc (Issuer)
Silence Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/22/2025
9:35 AM		Griffiths Richard Ian (Reporting)
Silence Therapeutics plc (Issuer)
Silence Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/15/2025
1:17 PM		Griffiths Richard Ian (Reporting)
Silence Therapeutics plc (Issuer)
Silence Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/01/2025
6:50 AM		Griffiths Richard Ian (Reporting)
Silence Therapeutics plc (Issuer)
Silence Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/31/2025
9:47 AM		Griffiths Richard Ian (Reporting)
Silence Therapeutics plc (Issuer)
Silence Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/31/2025
9:50 AM		Griffiths Richard Ian (Filed by)
Silence Therapeutics plc (Subject)
Silence Therapeutics (Subject)
Form SCHEDULE 13D/A
03/06/2025
10:03 AM		Griffiths Richard Ian (Reporting)
Silence Therapeutics plc (Issuer)
Silence Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/27/2025
4:20 PM		Silence Therapeutics plc (Filer)
Silence Therapeutics (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
02/27/2025
3:30 PM		Silence Therapeutics plc (Filer)
Silence Therapeutics (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
Trump’s national nightmare is here (Ad)

Porter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger the biggest forced rotation of capital since World War II. They reveal why Trump is mobilizing America’s tech giants… and name the two stocks most likely to soar as trillions shift behind the scenes.tc pixel

Watch the National Emergency broadcast here
02/27/2025
3:13 PM		Silence Therapeutics plc (Filer)
Silence Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/25/2025
9:59 AM		Griffiths Richard Ian (Reporting)
Silence Therapeutics plc (Issuer)
Silence Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/14/2025
7:03 PM		Redmile Group, LLC (Filed by)
Silence Therapeutics plc (Subject)
Silence Therapeutics (Subject)
Form SCHEDULE 13G
02/11/2025
5:41 PM		Lombard Odier Asset Management Corp (0001491719) (Filed by)
Silence Therapeutics plc (Subject)
Silence Therapeutics (Subject)
Form SCHEDULE 13G/A
01/02/2025
3:32 PM		HELLUMS RHONDA LYNETTE (Reporting)
Silence Therapeutics plc (Issuer)
Silence Therapeutics (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
01/02/2025
3:34 PM		Davidson Michael H. (Reporting)
Silence Therapeutics plc (Issuer)
Silence Therapeutics (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
01/02/2025
3:36 PM		Ede-Golightly James (Reporting)
Silence Therapeutics plc (Issuer)
Silence Therapeutics (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
01/02/2025
3:38 PM		Ross Iain (Reporting)
Silence Therapeutics plc (Issuer)
Silence Therapeutics (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
01/02/2025
3:39 PM		Silence Therapeutics plc (Issuer)
Silence Therapeutics (Issuer)
TOOMAN CRAIG A (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
01/02/2025
3:43 PM		Griffiths Richard Ian (Reporting)
Silence Therapeutics plc (Issuer)
Silence Therapeutics (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
01/02/2025
7:00 AM		Silence Therapeutics plc (Filer)
Silence Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/20/2024
4:32 PM		Griffiths Richard Ian (Filed by)
Silence Therapeutics plc (Subject)
Silence Therapeutics (Subject)
Form SCHEDULE 13D/A
12/09/2024
7:12 AM		Silence Therapeutics plc (Filer)
Silence Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
11/18/2024
3:54 PM		Silence Therapeutics plc (Filer)
Silence Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
11/14/2024
8:44 AM		Deep Track Capital, LP (Filed by)
Silence Therapeutics plc (Subject)
Silence Therapeutics (Subject)
Form SC 13G/A
11/14/2024
8:24 AM		Silence Therapeutics plc (Filer)
Silence Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
10/22/2024
4:20 PM		Silence Therapeutics plc (Filer)
Silence Therapeutics (Filer)
Form F-3ASR
(Data available from 1/1/2016 forward)


Related Companies and Tools

Related Companies
SEC Filings Tools

This page (NASDAQ:SLN) was last updated on 8/23/2025 by MarketBeat.com Staff
From Our Partners
BONUS GUIDE - Ben Stein Prepares For the Next Financial Crisis
With inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...
Goldco Precious Metals | Sponsoredtc pixel
GENIUS Act: Cancel Your Money?
A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...
Priority Gold | Sponsoredtc pixel
Alex’s “Next Magnificent Seven” stocks
The original “Magnificent Seven” turned $7K into $1.18 million. Now, Alex Green has identified AI’s Next Ma...
The Oxford Club | Sponsoredtc pixel
Elon’s Secret Social Security Bombshell
To All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...
Banyan Hill Publishing | Sponsoredtc pixel
The $7 company helping Nvidia build the world’s first trillion-dollar robot …
Michael Robinson has been at the forefront of the technology market for over 40 years. Spotting some profit...
Weiss Ratings | Sponsoredtc pixel
Everyone’s watching Nvidia right now. Here’s why I’m excited.
So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...
Timothy Sykes | Sponsoredtc pixel
INVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting Off
Right now, we’re witnessing a monumental shift in the world.
Traders Agency | Sponsoredtc pixel
Trump set to Boost Social Security Checks by 400%?
If you're collecting or planning to collect social security... You should see this presentation about Presi...
InvestorPlace | Sponsoredtc pixel